We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

55 hedge funds and large institutions have $285M invested in iKang Healthcare Group, Inc. in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

8% less funds holding

Funds holding: 6055 (-5)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

18% less capital invested

Capital invested by funds: $348M → $285M (-$63M)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

67% less call options, than puts

Call options by funds: $11.8M | Put options by funds: $36.3M

Holders
55
Holders Change
-5
Holders Change %
-8.33%
% of All Funds
1.37%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
7
Increased
19
Reduced
18
Closed
9
Calls
$11.8M
Puts
$36.3M
Net Calls
-$24.5M
Net Calls Change
+$28.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$64M -$60.3K -3,667 -0.1%
FI
2
Fosun International
China
$37.2M
QF
3
QVT Financial
New York
$22.8M +$2.62M +159,203 +11%
GP
4
GLG Partners
United Kingdom
$22.2M +$57.1K +3,471 +0.2%
Group One Trading
5
Group One Trading
Illinois
$20.6M -$3.99M -242,417 -15%
MCP
6
Maso Capital Partners
Hong Kong
$17.3M +$329K +20,000 +2%
ASI
7
All-Stars Investment
Hong Kong
$14M -$1.42M -86,395 -8%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$12.2M -$7.82M -475,351 -36%
BlackRock
9
BlackRock
New York
$9.49M +$10.5M +639,306 +6,134%
OAM
10
Oxford Asset Management
United Kingdom
$8.76M
First Manhattan
11
First Manhattan
New York
$7.53M
CS
12
Credit Suisse
Switzerland
$5.14M -$866K -52,672 -13%
Morgan Stanley
13
Morgan Stanley
New York
$5.02M +$2.39M +145,479 +73%
Millennium Management
14
Millennium Management
New York
$4.95M +$5.14M +312,608 +1,184%
CI
15
Conning Inc
Connecticut
$4.38M
EPM
16
Equitec Proprietary Markets
Illinois
$3.88M -$1.25M -76,031 -22%
OAM
17
Oberweis Asset Management
Illinois
$3.72M -$582K -35,400 -12%
Fidelity International
18
Fidelity International
Bermuda
$3.63M -$2.64M -160,876 -39%
CL
19
CSS LLC
Illinois
$2.33M +$899K +54,700 +52%
State Street
20
State Street
Massachusetts
$1.88M +$140K +8,502 +7%
TCIM
21
TIAA CREF Investment Management
New York
$1.56M -$125K -7,600 -7%
Northern Trust
22
Northern Trust
Illinois
$1.52M +$684K +41,579 +67%
Parallax Volatility Advisers
23
Parallax Volatility Advisers
California
$1.28M +$1.44M +87,536 New
Invesco
24
Invesco
Georgia
$1.17M +$22.6K +1,375 +2%
Citadel Advisors
25
Citadel Advisors
Florida
$982K -$1.64M -100,015 -60%

KANG Hedge Fund Activity: Q1 2017 in Review

55 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q1 2017, worth a combined $285M — down 18% from $348M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of KANG and 7 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 19 added.

The largest buyer was BlackRock, adding an estimated $10.5M. The largest seller was Susquehanna International Group, cutting an estimated $7.82M.

  • 55 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q1 2017, down from 60 in Q4 2016.
  • Funds reported $285M of iKang Healthcare Group, Inc. stock for Q1 2017, down 18% quarter-over-quarter.
  • 7 funds opened new iKang Healthcare Group, Inc. positions in Q1 2017 and 9 closed out, a net change of -2 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q1 2017 was BlackRock, an estimated $10.5M added.
  • The largest iKang Healthcare Group, Inc. seller in Q1 2017 was Susquehanna International Group, an estimated $7.82M sold.

Based on aggregated 13F filings for Q1 2017.